| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anal cancer brachytherapy: From radon seeds to interstitial Papillon technique in a century. What does the future hold?
|
Petric, Primoz
|
|
|
169 |
C |
p. 25-34
|
artikel
|
| 2 |
A novel treatment for malignant spasticity: The therapeutic use of stereotactic radiosurgery (SRS)
|
Nicosia, Luca
|
|
|
169 |
C |
p. 86-89
|
artikel
|
| 3 |
Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC – Hypothesis generation on a multicentre cohort of the DKTK-ROG
|
Löck, Steffen
|
|
|
169 |
C |
p. 8-14
|
artikel
|
| 4 |
Clinical necessity of multi-image based (4DMIB) optimization for targets affected by respiratory motion and treated with scanned particle therapy – A comprehensive review
|
Knopf, Antje-Christin
|
|
|
169 |
C |
p. 77-85
|
artikel
|
| 5 |
Comment on “Photobiomodulation therapy for the prevention of acute radiation dermatitis (ARD) in head and neck cancer patients (DERMISHEAD trial)”
|
He, Jian
|
|
|
169 |
C |
p. 142
|
artikel
|
| 6 |
Comment to “Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma – A systematic review and meta-analysis”
|
Kao, Yung-Shuo
|
|
|
169 |
C |
p. 163
|
artikel
|
| 7 |
Computer-aided segmentation on MRI for prostate radiotherapy, part II: Comparing human and computer observer populations and the influence of annotator variability on algorithm variability
|
Sanders, Jeremiah W.
|
|
|
169 |
C |
p. 132-139
|
artikel
|
| 8 |
Computer-aided segmentation on MRI for prostate radiotherapy, Part I: Quantifying human interobserver variability of the prostate and organs at risk and its impact on radiation dosimetry
|
Sanders, Jeremiah W.
|
|
|
169 |
C |
p. 124-131
|
artikel
|
| 9 |
Contents
|
|
|
|
169 |
C |
p. v-vi
|
artikel
|
| 10 |
Corrigendum to “DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients” [Radiother Oncol (2021) 164:146-154]
|
Huang, Weiyuan
|
|
|
169 |
C |
p. 168
|
artikel
|
| 11 |
Corrigendum to “Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma – A systematic review and meta-analysis” [Radiother. Oncol. 165 (2021) 37–43]
|
Chow, Ronald
|
|
|
169 |
C |
p. 165-167
|
artikel
|
| 12 |
Deep learning driven predictive treatment planning for adaptive radiotherapy of lung cancer
|
Lee, Donghoon
|
|
|
169 |
C |
p. 57-63
|
artikel
|
| 13 |
Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface
|
Ludwig, Roman
|
|
|
169 |
C |
p. 1-7
|
artikel
|
| 14 |
Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer
|
Lalonde, Ronald
|
|
|
169 |
C |
p. 90-95
|
artikel
|
| 15 |
Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial
|
Bonomo, Pierluigi
|
|
|
169 |
C |
p. 64-70
|
artikel
|
| 16 |
Early PSA density kinetics predicts biochemical and local failure following extreme hypofractionated radiotherapy in intermediate-risk prostate cancer
|
Greco, Carlo
|
|
|
169 |
C |
p. 35-42
|
artikel
|
| 17 |
Editorial Board
|
|
|
|
169 |
C |
p. ii
|
artikel
|
| 18 |
Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence
|
Mungmunpuntipantip, Rujittika
|
|
|
169 |
C |
p. 145
|
artikel
|
| 19 |
Innovation, value and reimbursement in radiation and complex surgical oncology: Time to rethink
|
Borras, Josep M.
|
|
|
169 |
C |
p. 114-123
|
artikel
|
| 20 |
In regard to Hess et al.
|
Finazzi, Tobias
|
|
|
169 |
C |
p. 140
|
artikel
|
| 21 |
In response to Finazzi and Papachristofilou
|
Hess, Clayton B.
|
|
|
169 |
C |
p. 141
|
artikel
|
| 22 |
Letter to the editor regarding the article “Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma – A systematic review and meta-analysis” by Chow et al.
|
Zhu, Jie
|
|
|
169 |
C |
p. 152-153
|
artikel
|
| 23 |
Major adverse cardiac event risk prediction model incorporating baseline Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose in lung cancer (CHyLL)
|
Tjong, Michael C.
|
|
|
169 |
C |
p. 105-113
|
artikel
|
| 24 |
Palliative radiotherapy for cancer patients with interstitial lung disease: A physician's perspective
|
Ikeda, Satoshi
|
|
|
169 |
C |
p. 155-156
|
artikel
|
| 25 |
Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting
|
Müller, Johannes
|
|
|
169 |
C |
p. 96-104
|
artikel
|
| 26 |
Reply to: Stereotactic radiotherapy needs more evidence before it can be used routinely to treat metastases: A comment on the paper by Nicosia et al
|
Nicosia, Luca
|
|
|
169 |
C |
p. 161-162
|
artikel
|
| 27 |
Response to “Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence”
|
Schoonbeek, Rosanne C.
|
|
|
169 |
C |
p. 146-147
|
artikel
|
| 28 |
Response to Kao and Chen
|
Chow, Ronald
|
|
|
169 |
C |
p. 164
|
artikel
|
| 29 |
Response to palliative radiotherapy for cancer patients with interstitial lung disease: A physician's perspective
|
Okumura, Masayuki
|
|
|
169 |
C |
p. 157-158
|
artikel
|
| 30 |
Response to the Comment on “Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)” by He et al.
|
Robijns, Jolien
|
|
|
169 |
C |
p. 143-144
|
artikel
|
| 31 |
Response to Zhu et al re “Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy and esophagectomy for the treatment of esophageal and gastroesophageal carcinoma - A systematic review and meta-analysis”
|
Chow, Ronald
|
|
|
169 |
C |
p. 154
|
artikel
|
| 32 |
Seminal vesicle inter- and intra-fraction motion during radiotherapy for prostate cancer: A review
|
Brand, Victor J.
|
|
|
169 |
C |
p. 15-24
|
artikel
|
| 33 |
Stereotactic radiotherapy needs more evidence before it can be used routinely to treat metastases: A comment on the paper by Nicosia et al
|
Macbeth, Fergus
|
|
|
169 |
C |
p. 159-160
|
artikel
|
| 34 |
Technical challenges in the treatment of mediastinal lymphomas by proton pencil beam scanning and deep inspiration breath-hold
|
Righetto, Roberto
|
|
|
169 |
C |
p. 43-50
|
artikel
|
| 35 |
Testosterone levels and testosterone kinetics: The importance of its clinical significance
|
Zapatero, Almudena
|
|
|
169 |
C |
p. 148-149
|
artikel
|
| 36 |
The importance of appropriate castrate level measurements of serum testosterone in prostate cancer patients
|
Morote, Juan
|
|
|
169 |
C |
p. 150-151
|
artikel
|
| 37 |
Timing of Ga68-PSMA PETCT and patterns of recurrence after prostate radiotherapy: Implications for potential salvage
|
Maitre, Priyamvada
|
|
|
169 |
C |
p. 71-76
|
artikel
|
| 38 |
Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
|
Correa, Rohann J.M.
|
|
|
169 |
C |
p. 51-56
|
artikel
|
Tijdschrift beschrijving